Oric Pharmaceuticals, Inc. (ORIC) — Institutional Holders, Q2 2026
181 institutional investment managers reported a ORIC position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $1.3B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ORIC in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- D. E. ShawAdded · +1,535,826 sh+$16.6M
- AIHC Capital Management LtdAdded · +1,368,909 sh+$14.8M
- PRICE T ROWE ASSOCIATESAdded · +1,229,771 sh+$13.3M
- STATE STREETAdded · +1,191,804 sh+$12.9M
- ALGERT GLOBALAdded · +1,078,943 sh+$11.7M
Biggest sellers
- PFIZERTrimmed · -4,407,497 sh-$47.7M
- Paradigm Biocapital AdvisorsSold out · -1,701,217 sh-$18.4M
- Logos Global ManagementSold out · -950,000 sh-$10.3M
- ALKEON CAPITAL MANAGEMENTTrimmed · -765,000 sh-$8.3M
- VIKING GLOBAL INVESTORSTrimmed · -697,771 sh-$7.6M
ORIC 13F holders ranked 1–100 of 181
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | Nextech Invest, Ltd.#1 · 7,162,637 sh | 7,162,637 | $77.6M | 3.68% | 0.0% |
| 2 | BlackRock#2 · 6,823,973 sh | 6,823,973 | $73.9M | <0.01% | +14.0% |
| 3 | EcoR1 Capital#3 · 6,728,116 sh | 6,728,116 | $72.9M | 3.54% | 0.0% |
| 4 | PRICE T ROWE ASSOCIATES#4 · 6,617,554 sh | 6,617,554 | $71.7M | <0.01% | +22.8% |
| 5 | VIKING GLOBAL INVESTORS#5 · 5,126,762 sh | 5,126,762 | $55.5M | 0.16% | -12.0% |
| 6 | STATE STREET#6 · 4,894,000 sh | 4,894,000 | $53.0M | <0.01% | +32.2% |
| 7 | SR ONE CAPITAL MANAGEMENT#7 · 4,615,384 sh | 4,615,384 | $50.0M | 4.81% | +2.2% |
| 8 | VR Adviser#8 · 4,319,765 sh | 4,319,765 | $46.8M | 1.42% | 0.0% |
| 9 | NEA Management Company#9 · 4,118,621 sh | 4,118,621 | $44.6M | 2.81% | 0.0% |
| 10 | VANGUARD CAPITAL MANAGEMENT#10 · 3,951,169 sh | 3,951,169 | $42.8M | <0.01% | +7.2% |
| 11 | AIHC Capital Management Ltd#11 · 3,828,460 sh | 3,828,460 | $41.5M | 39.77% | +55.7% |
| 12 | ALKEON CAPITAL MANAGEMENT#12 · 3,739,096 sh | 3,739,096 | $40.5M | 0.05% | -17.0% |
| 13 | Column Group#13 · 3,540,777 sh | 3,540,777 | $38.3M | 43.53% | 0.0% |
| 14 | Siren, L.L.C.#14 · 2,998,192 sh | 2,998,192 | $32.5M | 0.66% | 0.0% |
| 15 | FMR#15 · 2,635,475 sh | 2,635,475 | $28.5M | <0.01% | +8.3% |
| 16 | CITADEL ADVISORS#16 · 2,595,299 sh | 2,595,299 | $28.1M | <0.01% | +7.1% |
| 17 | GOLDMAN SACHS GROUP#17 · 2,451,796 sh | 2,451,796 | $26.6M | <0.01% | +66.1% |
| 18 | GEODE CAPITAL MANAGEMENT#18 · 2,090,089 sh | 2,090,089 | $22.6M | <0.01% | +13.7% |
| 19 | First Turn Management#19 · 2,017,284 sh | 2,017,284 | $21.8M | 2.34% | 0.0% |
| 20 | ORBIMED ADVISORS#20 · 2,015,000 sh | 2,015,000 | $21.8M | 0.40% | -25.2% |
| 21 | Integral Health Asset Management#21 · 1,900,000 sh | 1,900,000 | $20.6M | 0.81% | +35.7% |
| 22 | MPM BioImpact#22 · 1,882,162 sh | 1,882,162 | $20.4M | 1.24% | +4.3% |
| 23 | Vivo Capital#23 · 1,848,786 sh | 1,848,786 | $20.0M | 1.83% | 0.0% |
| 24 | DIMENSIONAL FUND ADVISORS#24 · 1,801,399 sh | 1,801,399 | $19.5M | <0.01% | +22.4% |
| 25 | FRANKLIN RESOURCES#25 · 1,797,377 sh | 1,797,377 | $19.5M | <0.01% | +23.7% |
| 26 | MORGAN STANLEY#26 · 1,794,020 sh | 1,794,020 | $19.4M | <0.01% | +6.6% |
| 27 | D. E. Shaw#27 · 1,580,216 sh | 1,580,216 | $17.1M | <0.01% | +3459.8% |
| 28 | Woodline Partners#28 · 1,247,515 sh | 1,247,515 | $13.5M | 0.04% | 0.0% |
| 29 | ALGERT GLOBAL#29 · 1,215,293 sh | 1,215,293 | $13.2M | 0.16% | +791.3% |
| 30 | BRAIDWELL#30 · 1,214,540 sh | 1,214,540 | $13.2M | 0.49% | +7.7% |
| 31 | Candriam S.C.A.#31 · 1,179,768 sh | 1,179,768 | $12.8M | 0.06% | +105.5% |
| 32 | BANK OF AMERICA#32 · 1,078,055 sh | 1,078,055 | $11.7M | <0.01% | +3.3% |
| 33 | ADAGE CAPITAL PARTNERS GP, L.L.C.#33 · 1,051,903 sh | 1,051,903 | $11.4M | 0.02% | +205.5% |
| 34 | Defilade Capital Management, L.P.#34 · 1,047,690 sh | 1,047,690 | $11.3M | 1.52% | +24.3% |
| 35 | Euclidean Capital#35 · 989,410 sh | 989,410 | $10.7M | 2.44% | 0.0% |
| 36 | ROYCE & ASSOCIATES#36 · 979,664 sh | 979,664 | $10.6M | 0.09% | -18.8% |
| 37 | EVENTIDE ASSET MANAGEMENT#37 · 954,768 sh | 954,768 | $10.3M | 0.14% | +0.1% |
| 38 | NORTHERN#38 · 806,304 sh | 806,304 | $8.7M | <0.01% | +13.4% |
| 39 | Qube Research & Technologies Ltd#39 · 794,542 sh | 794,542 | $8.6M | <0.01% | -7.6% |
| 40 | SPHERA FUNDS MANAGEMENT LTD.#40 · 752,983 sh | 752,983 | $8.2M | 1.06% | +40.1% |
| 41 | Jones Hill Capital#41 · 747,313 sh | 747,313 | $8.1M | 1.72% | New |
| 42 | SILVERARC CAPITAL MANAGEMENT#42 · 738,873 sh | 738,873 | $8.0M | 0.83% | -32.8% |
| 43 | NEXTBio Capital Management#43 · 706,124 sh | 706,124 | $7.6M | 3.52% | +34.9% |
| 44 | MILLENNIUM MANAGEMENT#44 · 697,694 sh | 697,694 | $7.6M | <0.01% | +1951.3% |
| 45 | CHARLES SCHWAB INVESTMENT MANAGEMENT#45 · 677,823 sh | 677,823 | $7.3M | <0.01% | +12.0% |
| 46 | VANGUARD PORTFOLIO MANAGEMENT#46 · 628,682 sh | 628,682 | $6.8M | <0.01% | +10.2% |
| 47 | TWO SIGMA INVESTMENTS#47 · 603,664 sh | 603,664 | $6.5M | <0.01% | New |
| 48 | ArrowMark Colorado#48 · 582,875 sh | 582,875 | $6.3M | 0.26% | -39.3% |
| 49 | VANGUARD FIDUCIARY#49 · 566,038 sh | 566,038 | $6.1M | <0.01% | +11.6% |
| 50 | Connor, Clark & Lunn Investment Management Ltd.#50 · 518,460 sh | 518,460 | $5.6M | 0.01% | -0.7% |
| 51 | SUPERSTRING CAPITAL MANAGEMENT#51 · 406,077 sh | 406,077 | $4.4M | 2.78% | +252.4% |
| 52 | Blue Owl Capital#52 · 400,000 sh | 400,000 | $4.3M | 0.65% | +166.7% |
| 53 | VICTORY CAPITAL MANAGEMENT#53 · 393,070 sh | 393,070 | $4.3M | <0.01% | -3.0% |
| 54 | Redmile Group#54 · 362,010 sh | 362,010 | $3.9M | 0.26% | -12.9% |
| 55 | AQR CAPITAL MANAGEMENT#55 · 358,751 sh | 358,751 | $3.9M | <0.01% | +110.9% |
| 56 | Boxer Capital Management#56 · 350,000 sh | 350,000 | $3.8M | 0.29% | +98.3% |
| 57 | BNP PARIBAS FINANCIAL MARKETS#57 · 345,038 sh | 345,038 | $3.7M | <0.01% | +1535.2% |
| 58 | Squarepoint Ops#58 · 344,343 sh | 344,343 | $3.7M | <0.01% | New |
| 59 | PFIZER#59 · 372,904 sh | 372,904 | $3.6M | 2.09% | -92.2% |
| 60 | JPMORGAN CHASE#60 · 308,268 sh | 308,268 | $3.1M | <0.01% | -4.7% |
| 61 | CITIGROUP#61 · 248,757 sh | 248,757 | $2.7M | <0.01% | +1363.8% |
| 62 | TD ASSET MANAGEMENT#62 · 246,002 sh | 246,002 | $2.7M | <0.01% | -4.9% |
| 63 | UBS Group AG#63 · 222,923 sh | 222,923 | $2.4M | <0.01% | +14.5% |
| 64 | Trexquant Investment#64 · 221,819 sh | 221,819 | $2.4M | 0.01% | +825.3% |
| 65 | Bank of New York Mellon#65 · 220,080 sh | 220,080 | $2.4M | <0.01% | +15.5% |
| 66 | XTX Topco Ltd#66 · 217,827 sh | 217,827 | $2.4M | 0.03% | +403.2% |
| 67 | WELLINGTON MANAGEMENT GROUP LLP#67 · 213,373 sh | 213,373 | $2.3M | <0.01% | +14.7% |
| 68 | MANUFACTURERS LIFE INSURANCE COMPANY, THE#68 · 174,222 sh | 174,222 | $1.9M | <0.01% | -4.3% |
| 69 | Nuveen#69 · 172,167 sh | 172,167 | $1.9M | <0.01% | +12.5% |
| 70 | AMERICAN CENTURY COMPANIES#70 · 168,628 sh | 168,628 | $1.8M | <0.01% | +14.9% |
| 71 | HRT FINANCIAL#71 · 153,245 sh | 153,245 | $1.7M | <0.01% | New |
| 72 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#72 · 139,266 sh | 139,266 | $1.5M | <0.01% | +504.1% |
| 73 | Jump Financial#73 · 131,400 sh | 131,400 | $1.4M | 0.01% | New |
| 74 | Atom Investors#74 · 130,079 sh | 130,079 | $1.4M | 0.13% | -42.6% |
| 75 | Ishara Investments#75 · 123,000 sh | 123,000 | $1.3M | 0.98% | +20.0% |
| 76 | Invesco Ltd.#76 · 107,773 sh | 107,773 | $1.2M | <0.01% | -1.1% |
| 77 | Russell Investments Group, Ltd.#77 · 99,742 sh | 99,742 | $1.1M | <0.01% | -62.1% |
| 78 | RHUMBLINE ADVISERS#78 · 93,919 sh | 93,919 | $1.0M | <0.01% | +18.8% |
| 79 | Rafferty Asset Management#79 · 90,763 sh | 90,763 | $983.0K | <0.01% | -21.4% |
| 80 | Abu Dhabi Investment Council P.J.S.C#80 · 89,441 sh | 89,441 | $968.6K | 0.14% | 0.0% |
| 81 | WELLS FARGO & COMPANY#81 · 87,009 sh | 87,009 | $942.3K | <0.01% | +122.5% |
| 82 | Swiss National Bank#82 · 86,200 sh | 86,200 | $933.5K | <0.01% | 0.0% |
| 83 | WINTON GROUP Ltd#83 · 83,000 sh | 83,000 | $898.9K | 0.03% | New |
| 84 | ALLIANCEBERNSTEIN L.P.#84 · 63,810 sh | 63,810 | $808.5K | <0.01% | 0.0% |
| 85 | DEUTSCHE BANK AG\#85 · 73,878 sh | 73,878 | $800.1K | <0.01% | +43.9% |
| 86 | Optimize Financial#86 · 64,432 sh | 64,432 | $697.8K | 0.13% | +99.3% |
| 87 | Engineers Gate Manager#87 · 64,052 sh | 64,052 | $693.7K | <0.01% | New |
| 88 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#88 · 63,470 sh | 63,470 | $687.4K | <0.01% | +17.0% |
| 89 | Toroso Investments#89 · 57,977 sh | 57,977 | $627.9K | <0.01% | +0.7% |
| 90 | TEMA ETFS#90 · 57,977 sh | 57,977 | $627.9K | — | +1.3% |
| 91 | SG Americas Securities#91 · 52,089 sh | 52,089 | $564.0K | <0.01% | +223.7% |
| 92 | Caption Management#92 · 48,130 sh | 48,130 | $521.2K | <0.01% | New |
| 93 | PROFUND ADVISORS#93 · 45,700 sh | 45,700 | $494.9K | 0.01% | -11.3% |
| 94 | MIRAE ASSET GLOBAL ETFS Ltd.#94 · 44,951 sh | 44,951 | $479.7K | <0.01% | +14.7% |
| 95 | MetLife Investment Management#95 · 43,840 sh | 43,840 | $474.8K | <0.01% | +22.8% |
| 96 | TUDOR INVESTMENT ET AL#96 · 42,409 sh | 42,409 | $459.3K | <0.01% | +25.9% |
| 97 | Virtus Investment Advisers#97 · 39,565 sh | 39,565 | $428.5K | 0.10% | +36.1% |
| 98 | AXQ CAPITAL#98 · 36,519 sh | 36,519 | $395.5K | 0.04% | New |
| 99 | Quadrature Capital Ltd#99 · 36,296 sh | 36,296 | $393.1K | <0.01% | New |
| 100 | LMR Partners LLP#100 · 35,267 sh | 35,267 | $381.9K | <0.01% | 0.0% |
Funds that sold out of ORIC in Q2 2026 (30)
Held ORIC at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.